UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis

Molecular cancer therapeutics, 2013-10, Vol.12 (10), p.1925-1934

2013

Volltextzugriff (PDF)

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Molecular cancer therapeutics, 2016-05, Vol.15 (5), p.1018-1028

2016

Volltextzugriff (PDF)

Reinventing the ACE inhibitors: some old and new implications of ACE inhibition

Hypertension research, 2010-01, Vol.33 (1), p.11-21

2010

Volltextzugriff (PDF)

In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: Role of pro-apoptotic effects of oleanolic acid and urosolic acid

Journal of ethnopharmacology, 2012-06, Vol.142 (1), p.72-79

2012

Volltextzugriff (PDF)

Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma

International journal of cancer, 2017-11, Vol.141 (9), p.1856-1866

2017

Volltextzugriff (PDF)

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (8), p.2316-2327

2014

Volltextzugriff (PDF)

p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage

The Journal of biological chemistry, 2014-02, Vol.289 (7), p.4083-4094

2014

Volltextzugriff (PDF)

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

Clinical cancer research, 2016-03, Vol.22 (5), p.1150-1160

2016

Volltextzugriff (PDF)

Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma

Molecular cancer therapeutics, 2023-04, Vol.22 (4), p.539-550

2023

Volltextzugriff (PDF)

ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis

Cancer research (Chicago, Ill.), 2014-01, Vol.74 (1), p.320-329

2014

Volltextzugriff (PDF)

Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.649-659

2012

Volltextzugriff (PDF)

Detection and Biological Activities of Carboxyethylpyrrole Ethanolamine Phospholipids (CEP-EPs)

Chemical research in toxicology, 2014-12, Vol.27 (12), p.2015-2022

2014

Volltextzugriff (PDF)

Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

Clinical cancer research, 2013-12, Vol.19 (24), p.6716-6729

2013

Volltextzugriff (PDF)

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

JCI insight, 2018-08, Vol.3 (16)

2018

Volltextzugriff (PDF)

Reciprocal regulation of microRNA‐122 and c‐Myc in hepatocellular cancer: Role of E2F1 and transcription factor dimerization partner 2

Hepatology (Baltimore, Md.), 2014-02, Vol.59 (2), p.555-566

2014

Volltextzugriff (PDF)

Hepatic Loss of miR-122 Predisposes Mice to Hepatobiliary Cyst and Hepatocellular Carcinoma upon Diethylnitrosamine Exposure

The American journal of pathology, 2013-12, Vol.183 (6), p.1719-1730

2013

Volltextzugriff (PDF)

Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy

Clinical cancer research, 2013-06, Vol.19 (11), p.2984-2994

2013

Volltextzugriff (PDF)

Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells

International journal of pharmaceutics, 2010-06, Vol.393 (1), p.186-197

2010

Volltextzugriff (PDF)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Oncoscience, 2014-03, Vol.1 (3), p.216-228

2014

Volltextzugriff (PDF)

Genetic polymorphism and pathogenesis of benign prostatic hyperplasia

BJU international, 2008-09, Vol.102 (5), p.536-544

2008

Volltextzugriff (PDF)

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities

Indian journal of human genetics, 2012-09, Vol.18 (3), p.274-275

2012

Volltextzugriff (PDF)

New cassane butenolide hemiketal diterpenes from the marine creeper Caesalpinia bonduc and their antiproliferative activity

Tetrahedron letters, 2007-10, Vol.48 (40), p.7194-7198

2007

Volltextzugriff (PDF)

Association of vitamin‐D receptor (Fok‐I) gene polymorphism with bladder cancer in an Indian population

BJU international, 2007-04, Vol.99 (4), p.933-937

2007

Volltextzugriff (PDF)

Analysis of polymorphisms of tumor necrosis factor-α and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: Study from northern India

Journal of gastroenterology and hepatology, 2007-06, Vol.22 (6), p.920-924

2007

Volltextzugriff (PDF)

Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (1), p.283-287

2010

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(86)

Sprache

Englisch
(86)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Reinventing the ACE inhibitors: some old and new implications of ACE inhibition

In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: Role of pro-apoptotic effects of oleanolic acid and urosolic acid

Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma

ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis

Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2

Detection and Biological Activities of Carboxyethylpyrrole Ethanolamine Phospholipids (CEP-EPs)

Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

Reciprocal regulation of microRNA‐122 and c‐Myc in hepatocellular cancer: Role of E2F1 and transcription factor dimerization partner 2

Hepatic Loss of miR-122 Predisposes Mice to Hepatobiliary Cyst and Hepatocellular Carcinoma upon Diethylnitrosamine Exposure

Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy

Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Genetic polymorphism and pathogenesis of benign prostatic hyperplasia

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities

New cassane butenolide hemiketal diterpenes from the marine creeper Caesalpinia bonduc and their antiproliferative activity

Association of vitamin‐D receptor (Fok‐I) gene polymorphism with bladder cancer in an Indian population

Analysis of polymorphisms of tumor necrosis factor-α and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: Study from northern India

Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer

Aktive Filter

Suchergebnisse filtern